The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 26, 2024

Filed:

Feb. 28, 2022
Applicant:

Industry-university Cooperation Foundation Hanyang University Erica Campus, Gyeonggi-do, KR;

Inventors:

Chul-Su Yang, Gyeonggi-do, KR;

Jae-Sung Kim, Gyeonggi-do, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61P 31/04 (2006.01); A23L 33/00 (2016.01); A23L 33/195 (2016.01); A61K 38/00 (2006.01); A61P 37/06 (2006.01); C07K 14/45 (2006.01);
U.S. Cl.
CPC ...
C07K 14/45 (2013.01); A23L 33/195 (2016.08); A23L 33/40 (2016.08); A61P 31/04 (2018.01); A61P 37/06 (2018.01); A23V 2002/00 (2013.01); A61K 38/00 (2013.01);
Abstract

The present invention relates to a pharmaceutical composition and a health functional food composition for preventing, alleviating or treating inflammatory diseases, includingGRA9 protein or a gene encoding the protein as an active ingredient. The present inventors have identified the C-terminal region essential for the NLRP3-mediated mechanism of action and function ofGRA9 in macrophages, which are host immune cells and confirmed the substantial anti-inflammatory and antibacterial effects and the antiseptic effect in vivo. Accordingly,GRA9 protein or a gene encoding the protein is expected to be usefully utilized in the field of prevention or treatment of inflammatory diseases caused by an abnormal NLRP3-mediated inflammatory response, including sepsis.


Find Patent Forward Citations

Loading…